SCHEMBL7574119

SCHEMBL7574119

O=C(O)C(Nc1ccc(Br)cc1F)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
LMNA P02545 7/20 0.54
NPC1 O15118 5/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
RAB9A P51151 4/20 0.54
MAPT P10636 5/20 0.49
ALOX12 P18054 3/20 0.47
FPR2 P25090 2/20 0.47
HPGD P15428 2/20 0.47
TP53 P04637 1/20 0.47
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.43
GAA P10253 2/20 0.43
HTT P42858 2/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7577631 0.85 FPR2 (0.49) ALDH1A1L3MBTL1LMNANPC1SMN1; SMN2
SCHEMBL7582068 0.85 ULK1 (0.54) ALDH1A1NPC1SMN1; SMN2RAB9AMAPT
SCHEMBL839473 0.84 MEN1 (0.50) ALDH1A1L3MBTL1LMNANPC1SMN1; SMN2
SCHEMBL14938214 0.83 LMNA (0.63) ALDH1A1L3MBTL1LMNANPC1SMN1; SMN2
SCHEMBL14948916 0.83 LMNA (0.63) ALDH1A1L3MBTL1LMNANPC1SMN1; SMN2
SCHEMBL7577550 0.82 PPARG (0.51) ALDH1A1L3MBTL1NPC1SMN1; SMN2RAB9A
SCHEMBL7578428 0.82 MAP2K1 (0.44) ALDH1A1L3MBTL1NPC1SMN1; SMN2RAB9A
SCHEMBL7585358 0.82 FPR2 (0.49) ALDH1A1L3MBTL1LMNANPC1SMN1; SMN2
SCHEMBL2484664 0.81 GAA (0.50) ALDH1A1LMNANPC1SMN1; SMN2RAB9A
SCHEMBL13241014 0.81 GAA (0.50) ALDH1A1LMNANPC1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed